期刊名称：THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Therapeutic Advances in Neurological Disorders
| Frequency: |
Published 6 times a year |
eISSN: 1756-2864 |
ISSN: 1756-2856 |
| Months of Distribution: |
January , March , May , July , September , November |
2013 Unofficial Impact Factor: 2.719
Source: Based on data from Thomson Reuters Web of KnowledgeSM
Therapeutic Advances in Neurological Disorders delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of neurology. You can access the journal online for free at www.sagepub.com/tan.
The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in neurology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all clinical areas of the field of neurology, concentrating on the more common non-cerebrovascular conditions.
It publishes expert opinion reviews (including single-drug and drug class reviews), narrative reviews and analysis of published guidelines (as editorials or reviews). Original research manuscripts of well-designed trials are also welcomed that show drug or drug class efficacy in a particular disease or therapeutic area. The journal strongly encourages the submission of original research with positive or negative results.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees - a first editorial decision is generally reached within 3 weeks of submission. Online publication of articles occurs within 7 weeks from acceptance. Further information for contributors is provided on the back pages of each issue and online.
This journal is a member of the Committee on Publication Ethics (COPE).
For all commercial sales and sponsorship enquiries, including advertising, reprints and supplements, please contact:
Commercial Sales Team, London, UK
Tel. +44 20 7336 1205
Email. reprints@sagepub.co.uk
Aims & Scope
The journal is aimed at clinicians and researchers in neurology and is a forum for presenting the latest research and reviews in this discipline, concentrating on the more-common non-cerebrovascular neurological disorders.
Topics covered include: neuroimmunology; movement and neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis - Lou Gehrig's disease, hemiballismus, tic disorder, and Gilles de la Tourette syndrome; pain; headache disorders such as migraine, cluster headache and tension headache; behavioralgnitive syndromes; sleep disorders; cerebral palsy; infections of the brain (encephalitis), brain meninges (meningitis), and spinal cord (myelitis);infections of the peripheral nervous system; neoplasms - tumors of the brain and its meninges (brain tumors), spinal cord tumors, tumors of the peripheral nerves (neuroma); demyelinating diseases of the central nervous system (such as multiple sclerosis), and of the peripheral nervous system (such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy - CIDP); spinal cord disorders - tumors, infections, trauma, malformations (eg, myelocele, meningomyelocele, tethered cord); disorders of peripheral nerves, muscle (myopathy) and neuromuscular junctions; traumatic injuries to the brain, spinal cord and peripheral nerves; altered mental status, encephalopathy, stupor and coma; speech and language disorders; epilepsy/seizure disorders.
Therapeutic Advances in Neurological Disorders adheres to a blinded peer review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Rapid Peer Review Process: Each research article and review manuscript is reviewed by at least two referees. All manuscripts are reviewed as rapidly as possible, and a first editorial decision is generally reached within 3 weeks of submission.
1. The purpose of the Journal is to publish (in the English language) articles, reviews and scholarly comment (judged worthy of publication by appropriate specialists and accepted by the Editor) relating to neurological disorders, pharmacology and medicine. The Journal is for all professionals and is a forum for all views on related subjects. The editorial board welcomes articles of current interest on original research, reviews and clinical studies.
2. The Journal will be international in the sense that it will seek, wherever possible, to publish material from authors with an international reputation and articles that are of interest to an international audience.
3. In pursuit of the above the journal shall:
(i) draw on and include high quality work from the international community of scholars including those in the major countries of Europe, Australasia, the United States, other parts of the Americas, countries in the Third World and elsewhere with due representation for considerations of the readership. The Journal shall include work representing the major areas of interest in contemporary research in neurological disorders and related medicine.
(ii) avoid bias in favour of the interests of particular schools or directions of research or particular political or narrow disciplinary objectives to the exclusion of others;
(iii) ensure that articles are written in a terminology and style which makes them intelligible, not merely within the context of a particular discipline or abstract mode, but across the domain of relevant disciplines.
Abstracting/Indexing
Chemical Abstracts Service (CAS)
Medscape
PubMed
Scopus
Instructions to Authors
Manuscript Submission
Editorial Board
Editor-in-Chief:
Dept of Neurology, Ruhr University Bochum, Bochum, Germany
Managing Editor:
SAGE Publications Ltd, London, UK
Associate Editors:
Thomas Jefferson University, Philadelphia, PA, USA
RKU - Universitäts- und Rehabilitationskliniken, Ulm, Germany
The University of San Antonio, USA
Hopitaux Universitaires Paris Sud (Bicetre), France
University College London, London, UK
Editorial Board:
| Ryuji Kaji |
Tokushima University Graduate School of Medicine, Tokushima, Japan |
| Michael Kaplitt |
Weill Medical College of Cornell University, New York, NY, USA |
| Ichizo Nishino |
National Center of Neurology and Psychiatry, Tokyo, Japan |
|
刊名字顺( Alphabetical List of Journals):
返回页首 